Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T Lymphocyte Modulator (TLM)
- Target
- TLM
- Molecular classification
- Cytokine, Co-stimulatory Molecule, Checkpoint Inhibitor, Growth Factor, Receptor, Other
01
Overview
A T lymphocyte modulator refers to any molecule, receptor, or agent that regulates the development, activation, function, or survival of T lymphocytes (T cells), which are a critical component of the adaptive immune system. These modulators can be endogenous proteins (such as cytokines or co-stimulatory molecules), synthetic drugs, or biological agents designed to enhance or suppress T cell responses.
- Other names
- T Cell ModulatorLymphocyte T-cell ImmunomodulatorLTCIT Cell Regulator
02
Mechanism of action
Modulation of T cell activation, proliferation, differentiation, or survival through various mechanisms, including co-stimulation, checkpoint inhibition, cytokine signaling, and direct modulation of T cell function.
03
Biological functions
Immune responseT cell activationT cell differentiationT cell proliferationCytokine productionApoptosis regulationImmune toleranceSignal transduction
04
Disease associations
CancerAutoimmune diseasesInfectionImmunodeficiencyTransplant rejectionInflammation
05
Safety considerations
Cytokine release syndromeAutoimmunityImmunosuppressionOpportunistic infectionsExacerbation of pre-existing autoimmune conditionsGraft-versus-host disease
06
Interacting drugs
Checkpoint inhibitors (e.g., Pembrolizumab, Nivolumab)
4 more in the full profile.
07
Biomarkers
CD4+ T cell countCD8+ T cell countCytokine levels (e.g., IL-2, IFN-gamma)Expression of checkpoint molecules (e.g., PD-1, CTLA-4)T cell receptor repertoireActivation markers (e.g., CD69)
Beyond the preview
Go deeper on T Lymphocyte Modulator (TLM).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T Lymphocyte Modulator (TLM).